SCHEMBL6990188

SCHEMBL6990188

CCOC(=O)c1cc(C)c(CC[C@H](O)CO[Si](C)(C)C(C)(C)C)s1

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HDAC3 O15379 2/20 0.36
HDAC4 P56524 1/20 0.36
HDAC1 Q13547 1/20 0.36
HDAC6 Q9UBN7 1/20 0.36
ALDH1A1 P00352 4/20 0.33
KDM4E B2RXH2 3/20 0.33
HPGD P15428 3/20 0.33
MAPT P10636 3/20 0.33
GAA P10253 3/20 0.33
NPC1 O15118 2/20 0.33
RAB9A P51151 2/20 0.33
TDP1 Q9NUW8 2/20 0.33
HTT P42858 1/20 0.33
SMN1; SMN2 Q16637 1/20 0.33
GLA P06280 1/20 0.33
ATM Q13315 1/20 0.33
L3MBTL1 Q9Y468 1/20 0.32
PTPN2 P17706 2/20 0.32
JAK2 O60674 1/20 0.32
JAK1 P23458 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6990186 1.00 HDAC3 (0.36) HDAC3HDAC4HDAC1HDAC6ALDH1A1
SCHEMBL6993503 0.83 HDAC3 (0.33) HDAC3HDAC4HDAC1HDAC6ALDH1A1
SCHEMBL6993500 0.83 HDAC3 (0.33) HDAC3HDAC4HDAC1HDAC6ALDH1A1
SCHEMBL6990850 0.83 HDAC3 (0.42) HDAC3HDAC4HDAC1HDAC6ALDH1A1
SCHEMBL6990853 0.83 HDAC3 (0.42) HDAC3HDAC4HDAC1HDAC6ALDH1A1
SCHEMBL6996548 0.81 HDAC3 (0.40) HDAC3HDAC4HDAC1HDAC6ALDH1A1
SCHEMBL8362199 0.81 HDAC3 (0.40) HDAC3HDAC4HDAC1HDAC6ALDH1A1
SCHEMBL7000933 0.75 SERPINE1 (0.38) HDAC3HDAC4HDAC1HDAC6ALDH1A1
SCHEMBL6170912 0.75 CYP4F2 (0.52) ALDH1A1KDM4EMAPTNPC1RAB9A
SCHEMBL8685062 0.75 ALDH1A1 (0.36) ALDH1A1KDM4EHPGDMAPTGAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0846111-B1 SYNTHESES OF OPTICALLY PURE COMPOUNDS USEFUL AS GARFT INHIBITORS AND THEIR INTERMEDIATES AGOURON PHARMA (US) 2003-08-27 EP disclosed
US-5981748-A Synthesis of optically pure compounds useful as GARFT inhibitors and their intermediates AGOURON PHARMACEUTICALS, INC. (US) 1999-11-09 US disclosed